Funds holding SAB Biotherapeutics Inc
ISIN US78397T2024 · United States
- Fund holders
- 12
- Of which ETFs
- 2 10 other funds
- Value held
- 11M $
- Share of capital
- 3.1 % of 91M shares on Aug 3, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 2,123,393 | 8.1M $ | 0.00 % | 2.33 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 304,894 | 1.2M $ | 0.00 % | 0.34 % | as of Mar 31, 2026 ↗ |
| Simplify Propel Opportunities ETF Simplify Exchange Traded Funds | 187,230 | 717.1K $ | 1.03 % | 0.21 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 47,303 | 193.9K $ | 0.00 % | 0.05 % | as of Feb 28, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 38,992 | 149.3K $ | 0.00 % | 0.04 % | as of Mar 31, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 37,595 | 144K $ | 0.00 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 32,163 | 131.9K $ | 0.00 % | 0.04 % | as of Feb 28, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 27,855 | 106.7K $ | 0.00 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Avantis U.S. Small Cap Equity ETF American Century ETF Trust | 25,572 | 104.8K $ | 0.00 % | 0.03 % | as of Feb 28, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 12,827 | 52.6K $ | 0.01 % | as of Feb 28, 2026 ↗ | |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 10,619 | 43.5K $ | 0.01 % | as of Feb 28, 2026 ↗ | |
| Victory Extended Market Index Fund Victory Portfolios III | 4,211 | 15.7K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table counts shares; this one measures what the company weighs inside each fund.
| Fund | Weight in fund | |
|---|---|---|
| Simplify Propel Opportunities ETF Simplify Exchange Traded Funds | 1.03 % | as of Mar 31, 2026 ↗ |
| Avantis U.S. Small Cap Equity ETF American Century ETF Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 0.00 % | as of Mar 31, 2026 ↗ |
| Victory Extended Market Index Fund Victory Portfolios III | 0.00 % | as of Apr 30, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each SEC quarterly data set, newest first. The change is read against the quarter before it.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 12 | +2 | 2,852,654 | +38.9 % |
| 2026Q1 | 10 | +4 | 2,053,849 | +447.0 % |
| 2025Q4 | 6 | -1 | 375,490 | +6.0 % |
| 2025Q3 | 7 | -1 | 354,136 | -2.1 % |
| 2025Q2 | 8 | 0 | 361,666 | +1.3 % |
| 2025Q1 | 8 | 0 | 357,094 | +3.2 % |
| 2024Q4 | 8 | +1 | 345,879 | +2.7 % |
| 2024Q3 | 7 | -1 | 336,833 | +60.4 % |
| 2024Q2 | 8 | +7 | 209,983 | +12,831.6 % |
| 2024Q1 | 1 | 1,624 |
Institutional managers
71 managers declare this company to the SEC (Form 13F); the 25 largest follow.
| Manager | Shares | Value | |
|---|---|---|---|
| Vivo Capital, LLC | 11,420,000 | 43.7M $ | as of Mar 31, 2026 |
| Caligan Partners LP | 7,967,207 | 30.5M $ | as of Mar 31, 2026 |
| PERCEPTIVE ADVISORS LLC | 6,431,743 | 24.6M $ | as of Mar 31, 2026 |
| Commodore Capital LP | 4,401,500 | 16.9M $ | as of Mar 31, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | 4,401,500 | 16.9M $ | as of Mar 31, 2026 |
| Balyasny Asset Management L.P. | 3,760,439 | 14.4M $ | as of Mar 31, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,405,553 | 13M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 3,032,697 | 11.6M $ | as of Mar 31, 2026 |
| Woodline Partners LP | 2,851,791 | 10.9M $ | as of Mar 31, 2026 |
| Spruce Street Capital LP | 2,198,502 | 8.4M $ | as of Mar 31, 2026 |
| Sessa Capital IM, L.P. | 2,198,457 | 8.4M $ | as of Mar 31, 2026 |
| BOOTHBAY FUND MANAGEMENT, LLC | 1,481,660 | 5.7M $ | as of Mar 31, 2026 |
| AMERIPRISE FINANCIAL INC | 1,476,106 | 5.7M $ | as of Mar 31, 2026 |
| Ensign Peak Advisors, Inc | 1,375,610 | 5.3M $ | as of Mar 31, 2026 |
| Soleus Capital Management, L.P. | 1,050,000 | 4M $ | as of Mar 31, 2026 |
| Propel Bio Management, LLC | 1,012,790 | 3.9M $ | as of Mar 31, 2026 |
| Jefferies Financial Group Inc. | 903,094 | 3.5M $ | as of Mar 31, 2026 |
| Blackstone Inc. | 860,170 | 3.3M $ | as of Mar 31, 2026 |
| Affinity Asset Advisors, LLC | 575,000 | 2.2M $ | as of Mar 31, 2026 |
| Monashee Investment Management LLC | 500,000 | 1.9M $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 463,925 | 1.8M $ | as of Mar 31, 2026 |
| AWM Investment Company, Inc. | 400,000 | 1.5M $ | as of Mar 31, 2026 |
| DV Trading LLC | 400,000 | 1.5M $ | as of Mar 31, 2026 |
| STEMPOINT CAPITAL LP | 375,000 | 1.4M $ | as of Mar 31, 2026 |
| HB Wealth Management, LLC | 307,500 | 1.2M $ | as of Mar 31, 2026 |
Declared shareholders of SAB Biotherapeutics Inc
4 beneficial ownership filings. These stakes do not add up: an asset manager filing aggregates its own funds, already counted above.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Caligan Partners LP and 1 other | 10.40 % | 7,967,207 | as of Mar 31, 2026 · SCHEDULE 13G |
| Balyasny Asset Management L.P. and 4 others | 9.99 % | 5,089,939 | as of Mar 31, 2026 · SCHEDULE 13G |
| Perceptive Advisors LLC and 2 others | 8.40 % | 6,431,743 | as of Mar 31, 2026 · SCHEDULE 13G |
| Millennium Management LLC and 2 others | 5.10 % | 3,432,153 | as of Apr 24, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding SAB Biotherapeutics Inc". https://titelia.com/en/stocks/sab-biotherapeutics-inc-US78397T2024